When Is Osteonecrosis Not Osteonecrosis? Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program

Marc C. Hochberg, Leslie A. Tive, Steven B. Abramson, Eric Vignon, Kenneth M. Verburg, Christine R. West, Michael D. Smith, David S. Hungerford

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'When Is Osteonecrosis Not Osteonecrosis? Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program'. Together they form a unique fingerprint.

Medicine & Life Sciences